| scholarly article | Q13442814 |
| P50 | author | Li Wen | Q88313570 |
| James A Pearson | Q57339799 | ||
| F. Susan Wong | Q63411298 | ||
| P2093 | author name string | Li Wen | |
| F Susan Wong | |||
| P2860 | cites work | Inhibition of experimental autoimmune myocarditis: peripheral deletion of TcR Vbeta 8.1, 8.2+ CD4+ T cells in TLR-4 deficient mice | Q81806617 |
| HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes | Q82625833 | ||
| A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease | Q84371124 | ||
| Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process | Q84389022 | ||
| Identification of autoreactive CD8+ T cell responses targeting chromogranin A in humanized NOD mice and type 1 diabetes patients | Q87277128 | ||
| Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice | Q87544988 | ||
| Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice | Q95789881 | ||
| The Spontaneously Diabetic Wistar Rat: Metabolic and Morphologic Studies | Q40750483 | ||
| Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria | Q41079821 | ||
| Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. | Q41103039 | ||
| Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study | Q41312022 | ||
| Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice. | Q41487658 | ||
| Characterization of antinuclear autoantibodies present in the serum from nonobese diabetic (NOD) mice | Q41529704 | ||
| The contribution of direct TLR signaling to T cell responses. | Q41585090 | ||
| TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes | Q41936111 | ||
| Long-term silencing of autoimmune diabetes and improved life expectancy by a soluble pHLA-DR4 chimera in a newly-humanized NOD/DR4/B7 mouse | Q41976808 | ||
| Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response | Q42263474 | ||
| Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. | Q43427160 | ||
| HLA-DQ8 transgenic and NOD mice recognize different epitopes within the cytoplasmic region of the tyrosine phosphatase-like molecule, IA-2. | Q43766136 | ||
| The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex | Q43926964 | ||
| Treatment of autoimmune diabetes in NOD mice by Toll-like receptor 2 tolerance in conjunction with dipeptidyl peptidase 4 inhibition | Q44146198 | ||
| Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease | Q44285977 | ||
| Radioassay determination of insulin autoantibodies in NOD mice. Correlation with increased risk of progression to overt diabetes | Q44456443 | ||
| The use of a non-depleting anti-CD4 monoclonal antibody to re-establish tolerance to beta cells in NOD mice. | Q44587253 | ||
| Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice | Q45201533 | ||
| TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats | Q45532280 | ||
| The role of antimicrobial peptides in innate immunity. | Q45972725 | ||
| Abul Abbas: an epitome of scholarship. | Q45978293 | ||
| Reduced numbers of dendritic cells with a tolerogenic phenotype in the prediabetic pancreas of NOD mice. | Q46076286 | ||
| Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. | Q46165238 | ||
| Induction of diabetes in the RIP-B7.1 mouse model is critically dependent on TLR3 and MyD88 pathways and is associated with alterations in the intestinal microbiome | Q46957607 | ||
| Delayed exposure to wheat and barley proteins reduces diabetes incidence in non-obese diabetic mice | Q47745073 | ||
| Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice | Q47753756 | ||
| Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice | Q50096775 | ||
| Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. | Q50787251 | ||
| Spatial clustering in childhood diabetes: evidence of an environmental cause. | Q51003528 | ||
| Polymorphism in the innate immune receptor SIRPα controls CD47 binding and autoimmunity in the nonobese diabetic mouse. | Q51026450 | ||
| Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. | Q51369994 | ||
| Uncoupling of anergy from developmental arrest in anti-insulin B cells supports the development of autoimmune diabetes. | Q52060984 | ||
| The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. | Q52196097 | ||
| Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. | Q52196099 | ||
| Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. | Q52226171 | ||
| The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. | Q53524050 | ||
| Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells. | Q53530398 | ||
| HL-A antigens and diabetes mellitus. | Q53741461 | ||
| Histocompatibility (HL-A) Antigens, Lymphocytotoxic Antibodies and Tissue Antibodies in Patients with Diabetes Mellitus | Q53919094 | ||
| Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice. | Q53971841 | ||
| B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. | Q54120741 | ||
| Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. | Q54412643 | ||
| Somatically mutated B cell pool provides precursors for insulin antibodies | Q56903328 | ||
| Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice | Q58312813 | ||
| Parental country of birth is a major determinant of childhood type 1 diabetes in Sweden | Q58617047 | ||
| Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain | Q59081148 | ||
| Prevention of autoimmune insulitis by expression of I–E molecules in NOD mice | Q59088106 | ||
| The Role of Toll-Like Receptors 3 and 9 in the Development of Autoimmune Diabetes in NOD Mice | Q59276520 | ||
| Lymphocyte abnormalities in the BB rat | Q59624522 | ||
| Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines | Q60333361 | ||
| Phenotype and Functional Characteristics of Islet-Infiltrating B-Cells Suggest the Existence of Immune Regulatory Mechanisms in Islet Milieu | Q60517247 | ||
| Phenotypic and Functional Characteristics of BM-Derived DC from NOD and Non-Diabetes-Prone Strains | Q62748597 | ||
| Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome | Q21132451 | ||
| A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease | Q22251291 | ||
| Chromogranin A is an autoantigen in type 1 diabetes | Q24605199 | ||
| The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity | Q24645048 | ||
| Innate immunity and intestinal microbiota in the development of Type 1 diabetes | Q24647312 | ||
| Function of Nod-like receptors in microbial recognition and host defense | Q24647448 | ||
| Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice | Q24669724 | ||
| Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. | Q24679680 | ||
| Genetics of type 1 diabetes | Q26866502 | ||
| Pathogen recognition and innate immunity | Q27861084 | ||
| NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells | Q28207942 | ||
| Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C | Q28270392 | ||
| Breeding of a non-obese, diabetic strain of mice | Q28276534 | ||
| Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection | Q28587620 | ||
| A microbial symbiosis factor prevents intestinal inflammatory disease | Q29614263 | ||
| Identification of Novel Type 1 Diabetes Candidate Genes by Integrating Genome-Wide Association Data, Protein-Protein Interactions, and Human Pancreatic Islet Gene Expression | Q30002303 | ||
| HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families | Q30411842 | ||
| Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. | Q30763625 | ||
| Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity | Q33220897 | ||
| Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection | Q33397372 | ||
| Increasing incidence of pediatric type 1 diabetes mellitus in Southeastern Wisconsin: relationship with body weight at diagnosis | Q33499699 | ||
| Development and function of human innate immune cells in a humanized mouse model | Q33596915 | ||
| Epidemiological perspectives on type 1 diabetes in childhood and adolescence in germany: 20 years of the Baden-württemberg Diabetes Incidence Registry (DIARY) | Q33602242 | ||
| Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells | Q33687787 | ||
| Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. | Q33716675 | ||
| Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment | Q33811836 | ||
| The Environmental Determinants of Diabetes in the Young (TEDDY) Study | Q33917733 | ||
| IRAK-M deficiency promotes the development of type 1 diabetes in NOD mice | Q33959795 | ||
| Compensatory mechanisms allow undersized anchor-deficient class I MHC ligands to mediate pathogenic autoreactive T cell responses | Q34053837 | ||
| NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets. | Q36056835 | ||
| Autoantigen-specific B-cell depletion overcomes failed immune tolerance in type 1 diabetes | Q36109213 | ||
| Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis | Q36339119 | ||
| Long-term remission of diabetes in NOD mice is induced by nondepleting anti-CD4 and anti-CD8 antibodies | Q36339650 | ||
| Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung | Q36362003 | ||
| CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. | Q36366075 | ||
| B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice | Q36367653 | ||
| In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes | Q36375838 | ||
| The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice | Q36401103 | ||
| Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement | Q36526326 | ||
| Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. | Q36603252 | ||
| Beta-lactam antibiotics modulate T-cell functions and gene expression via covalent binding to cellular albumin | Q36637602 | ||
| Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth | Q36766166 | ||
| B lymphocyte "original sin" in the bone marrow enhances islet autoreactivity in type 1 diabetes-prone nonobese diabetic mice | Q36920508 | ||
| Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children | Q36932173 | ||
| Intracellular NOD-like receptors in innate immunity, infection and disease | Q36974983 | ||
| Combination treatment with anti-CD20 and oral anti-CD3 prevents and reverses autoimmune diabetes. | Q37031014 | ||
| TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice. | Q37210998 | ||
| Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A | Q37245361 | ||
| A review of the current use of rituximab in autoimmune diseases | Q37322846 | ||
| Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice | Q37384851 | ||
| Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. | Q37476298 | ||
| A humanized mouse model of autoimmune insulitis. | Q37715564 | ||
| TLR signaling in B-cell development and activation. | Q37729362 | ||
| Teplizumab induces human gut-tropic regulatory cells in humanized mice and patients. | Q38328280 | ||
| Myeloid-derived suppressor cells in immunity and autoimmunity | Q38509763 | ||
| From defining antigens to new therapies in multiple sclerosis: honoring the contributions of Ruth Arnon and Michael Sela | Q39114536 | ||
| Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study | Q40088313 | ||
| Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. | Q40235770 | ||
| NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. | Q40345753 | ||
| Identification of naturally processed HLA-A2--restricted proinsulin epitopes by reverse immunology. | Q40404152 | ||
| Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse | Q40409987 | ||
| Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics. | Q40455088 | ||
| Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection | Q40497673 | ||
| Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/γcnull mice model | Q40656354 | ||
| Nonobese diabetic (NOD) mouse dendritic cells stimulate insulin secretion by prediabetic islets | Q40657321 | ||
| Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice | Q34097751 | ||
| Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies? | Q34099969 | ||
| The gene expression profile of CD11c+ CD8α- dendritic cells in the pre-diabetic pancreas of the NOD mouse | Q34104974 | ||
| Diabetes and gender | Q34155817 | ||
| Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study | Q34186708 | ||
| ZnT8-reactive T cells are weakly pathogenic in NOD mice but can participate in diabetes under inflammatory conditions | Q34227916 | ||
| Reduced diabetes in btk-deficient nonobese diabetic mice and restoration of diabetes with provision of an anti-insulin IgH chain transgene | Q34267426 | ||
| Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. | Q34307135 | ||
| NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells | Q34390898 | ||
| TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells | Q34468344 | ||
| Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice | Q34479316 | ||
| Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. | Q34566135 | ||
| The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique | Q34614636 | ||
| Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells | Q34630923 | ||
| Prevention of "Humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approach | Q34718795 | ||
| A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. | Q34728143 | ||
| Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice | Q34904815 | ||
| Analysis of islet inflammation in human type 1 diabetes. | Q34917032 | ||
| Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice. | Q34982303 | ||
| Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice | Q35005601 | ||
| Extreme genetic risk for type 1A diabetes | Q35024527 | ||
| Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in type 1 diabetes | Q35147560 | ||
| Long term effect of gut microbiota transfer on diabetes development | Q35157830 | ||
| The role of Gr1+ cells after anti-CD20 treatment in type 1 diabetes in nonobese diabetic mice | Q35180970 | ||
| The dual effects of B cell depletion on antigen-specific T cells in BDC2.5NOD mice | Q35180980 | ||
| Antibiotic treatment of pregnant non-obese diabetic mice leads to altered gut microbiota and intestinal immunological changes in the offspring | Q35195054 | ||
| Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial | Q35321191 | ||
| The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire | Q35602289 | ||
| Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. | Q35795065 | ||
| Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice | Q35913697 | ||
| Beyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes | Q35981325 | ||
| The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model | Q36017123 | ||
| T cell receptor restriction of diabetogenic autoimmune NOD T cells | Q36049067 | ||
| Transfer of Autoimmune Diabetes from Diabetic NOD Mice to NOD Athymic Nude Mice: The Roles of T Cell Subsets in the Pathogenesis | Q63965632 | ||
| Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study | Q67298313 | ||
| Remission of established disease in diabetic NOD mice induced by anti-CD3 monoclonal antibody | Q67969049 | ||
| Prevention of cyclophosphamide-induced and spontaneous diabetes in NOD/Shi/Kbe mice by anti-MHC class I Kd monoclonal antibody | Q68037541 | ||
| A Molecular Basis for MHC Class II—Associated Autoimmunity | Q68355418 | ||
| Recurrence of insulitis in the NOD mouse after early prolonged anti-CD4 monoclonal antibody treatment | Q69171827 | ||
| Insulin autoantibodies in non-obese diabetic (NOD) mice | Q69492420 | ||
| Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats | Q69554766 | ||
| Evidence for initial involvement of macrophage in development of insulitis in NOD mice | Q69830443 | ||
| Time course of the lymphopenia in BB rats. Relation to the onset of diabetes | Q69974798 | ||
| Diabetes in identical twins. A study of 200 pairs | Q70659026 | ||
| The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus | Q71420898 | ||
| Genetics of the BB rat: association of autoimmune disorders (diabetes, insulitis, and thyroiditis) with lymphopenia and major histocompatibility complex class II | Q71813277 | ||
| The BB diabetic rat. Profound T-cell lymphocytopenia | Q72094521 | ||
| Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors | Q72208453 | ||
| Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice | Q72387387 | ||
| Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice | Q72495270 | ||
| Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat | Q72779777 | ||
| Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes | Q72787287 | ||
| Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant | Q72787291 | ||
| Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice | Q73048923 | ||
| CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice | Q73128688 | ||
| Generation and maintenance of autoantigen-specific CD8(+) T cell clones isolated from NOD mice | Q73169623 | ||
| An islet-homing NOD CD8+ cytotoxic T cell clone recognizes GAD65 and causes insulitis | Q73174046 | ||
| Substitution of aspartic acid at beta57 with alanine alters MHC class II peptide binding activity but not protein stability: HLA-DQ (alpha1*0201, beta1*0302) and (alpha1*0201, beta1*0303) | Q73336570 | ||
| Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice | Q73375214 | ||
| Development of Insulitis and Diabetes in B Cell-Deficient NOD Mice | Q73501288 | ||
| Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group | Q73639505 | ||
| Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse | Q73650639 | ||
| Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei | Q73699745 | ||
| beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function | Q73783230 | ||
| Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States | Q73795625 | ||
| Islet cell autoimmunity in NOD mice transgenic for HLA-DQ8 and lacking I-Ag7 | Q74414686 | ||
| Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice | Q74607783 | ||
| B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice | Q77136854 | ||
| Intrinsic in vitro abnormalities in dendritic cell generation caused by non-MHC non-obese diabetic genes | Q77899232 | ||
| I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice | Q77967366 | ||
| Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes | Q78014697 | ||
| Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice | Q79318828 | ||
| Peritoneal B cells govern the outcome of diabetes in non-obese diabetic mice | Q80442791 | ||
| On the pathogenicity of autoantigen-specific T-cell receptors | Q80770958 | ||
| Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes | Q80813712 | ||
| Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice | Q80942355 | ||
| The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes | Q80972975 | ||
| Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study | Q81282208 | ||
| Small intestinal enteropathy in non-obese diabetic mice fed a diet containing wheat | Q81649672 | ||
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 76-88 | |
| P577 | publication date | 2015-09-21 | |
| P1433 | published in | Journal of Autoimmunity | Q15716783 |
| P1476 | title | The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes | |
| P478 | volume | 66 |
| Q57294149 | A severe atherosclerosis mouse model on the resistant NOD background |
| Q90325842 | A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves' disease |
| Q90534179 | Abnormal T-Cell Development in the Thymus of Non-obese Diabetic Mice: Possible Relationship With the Pathogenesis of Type 1 Autoimmune Diabetes |
| Q93062719 | Airway M Cells Arise in the Lower Airway Due to RANKL Signaling and Reside in the Bronchiolar Epithelium Associated With iBALT in Murine Models of Respiratory Disease |
| Q41504603 | Animal Models of Diabetic Retinopathy |
| Q56531810 | Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity |
| Q36277657 | Antibiotics, gut microbiota, environment in early life and type 1 diabetes. |
| Q90333805 | BET Proteins Are Required for Transcriptional Activation of the Senescent Islet Cell Secretome in Type 1 Diabetes |
| Q38818303 | Beta-cell specific autoantibodies: Are they just an indicator of type 1 diabetes? |
| Q39017669 | Beyond Genetics: What Causes Type 1 Diabetes |
| Q92991225 | Bisphenol S Modulates Type 1 Diabetes Development in Non-Obese Diabetic (NOD) Mice with Diet- and Sex-Related Effects |
| Q47567921 | Bridge between type 1 diabetes in mouse and man. |
| Q38692421 | Bringing the human pancreas into focus: new paradigms for the understanding of Type 1 diabetes. |
| Q57793435 | Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice |
| Q37358380 | Despite Increased Type 1 IFN, Autoimmune Nonobese Diabetic Mice Display Impaired Dendritic Cell Response to CpG and Decreased Nuclear Localization of IFN-Activated STAT1. |
| Q58745498 | Dietary Cows' Milk Protein A1 Beta-Casein Increases the Incidence of T1D in NOD Mice |
| Q51764522 | Differential role of MyD88 and TRIF signaling in myeloid cells in the pathogenesis of autoimmune diabetes. |
| Q64116567 | Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse Model |
| Q92735322 | Early functional alterations in membrane properties and neuronal degeneration are hallmarks of progressive hearing loss in NOD mice |
| Q49959004 | Effect of Early-life Gut Mucosal Compromise on Disease Progression in NOD Mice |
| Q90290369 | Environmental Factors Associated With Type 1 Diabetes |
| Q91711356 | Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms |
| Q58603842 | Evaluation of different mucosal microbiota leads to gut microbiota-based prediction of type 1 diabetes in NOD mice |
| Q37737490 | Exercise Training but not Curcumin Supplementation Decreases Immune Cell Infiltration in the Pancreatic Islets of a Genetically Susceptible Model of Type 1 Diabetes |
| Q38691330 | Expansion of FasL-Expressing CD5+ B Cells in Type 1 Diabetes Patients |
| Q28066824 | Experimental Diabetes Mellitus in Different Animal Models |
| Q38688772 | Genetic and Small Molecule Disruption of the AID/RAD51 Axis Similarly Protects Nonobese Diabetic Mice from Type 1 Diabetes through Expansion of Regulatory B Lymphocytes |
| Q97905937 | Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes |
| Q91936537 | Glycated Whey Proteins Protect NOD Mice against Type 1 Diabetes by Increasing Anti-Inflammatory Responses and Decreasing Autoreactivity to Self-Antigens |
| Q51144461 | Gut Microbiota and Type 1 Diabetes. |
| Q48108184 | Human immunology studies using organ donors: Impact of clinical variations on immune parameters in tissues and circulation. |
| Q60956625 | Humanized Mice Are Instrumental to the Study of Infection |
| Q52634041 | Humanizing the mouse immune system to study splanchnic organ inflammation. |
| Q92734901 | Immune Relevant and Immune Deficient Mice: Options and Opportunities in Translational Research |
| Q38937346 | Immunometabolism and autoimmunity |
| Q49790362 | MHC-mismatched mixed chimerism restores peripheral tolerance of noncross-reactive autoreactive T cells in NOD mice |
| Q49362193 | Mitochondrial Reactive Oxygen Species and Type 1 Diabetes |
| Q93142894 | N-Acetyl-l-Cysteine Supplement in Early Life or Adulthood Reduces Progression of Diabetes in Nonobese Diabetic Mice |
| Q64268733 | Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models? |
| Q91787668 | Oral therapy with colonization factor antigen I prevents development of type 1 diabetes in Non-obese Diabetic mice |
| Q92412734 | PAHSAs attenuate immune responses and promote β cell survival in autoimmune diabetic mice |
| Q94569735 | PPARs and the Development of Type 1 Diabetes |
| Q40998229 | PTPN22 and islet-specific autoimmunity: What have the mouse models taught us? |
| Q59080967 | Peptide secretion triggers diabetes |
| Q48534624 | Perturbation of the molecular clockwork in the SCN of non-obese diabetic mice prior to diabetes onset |
| Q64072310 | Probiotics and Prebiotics for the Amelioration of Type 1 Diabetes: Present and Future Perspectives |
| Q89253430 | Regulation of contact sensitivity in non-obese diabetic (NOD) mice by innate immunity |
| Q91843340 | Replacing murine insulin 1 with human insulin protects NOD mice from diabetes |
| Q36378893 | Reply to "Tolerogenic insulin peptide therapy precipitates type 1 diabetes". |
| Q99561822 | Roles of Noncoding RNAs in Islet Biology |
| Q92988627 | Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Strategies for In Vivo Administration: Part-II |
| Q33739020 | Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes |
| Q60046089 | The Aryl Hydrocarbon Receptor as an Immune-Modulator of Atmospheric Particulate Matter-Mediated Autoimmunity |
| Q59353295 | The Intestinal Virome and Immunity |
| Q52315444 | The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into "Old" Diseases. |
| Q90498144 | Tissue-specific autoimmunity controlled by Aire in thymic and peripheral tolerance mechanisms |
| Q38645059 | Tolerogenic Nanoparticles to Treat Islet Autoimmunity |
| Q90650262 | Type-I Interferons Inhibit Interleukin-10 Signaling and Favor Type 1 Diabetes Development in Nonobese Diabetic Mice |
Search more.